Clinical Trial Update: Budesonide in Patients With Immune Mediated Enteropathies [Phase 4]

View source ↗

Summary

Phase 4 trial on budesonide for immune-mediated enteropathies (terminated; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Enteropathy
• Celiac Disease
• Collagenous Sprue
• Cvid Enteropathy
• Enteropathy

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Mayo Clinic | Conditions: Enteropathy, Celiac Disease | Phase 4 | Status: TERMINATED | Results posted: 2022-08-26